Haiyang Zhang

Haiyang Zhang

Auto-generated profile, based on publicly available information

Haiyang Zhang

State Key Laboratory of Eye Health, Department of Ophthalmology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2025 in Journal of Medical Internet Research
Verified
Journal Article
Open access
ZZZili Zhang
Zili Zhang
HZHaiyang Zhang
Haiyang Zhang
ZPZhe Pan
Zhe Pan
ZBZhangqian Bi
Zhangqian Bi
YWYao Wan
Yao Wan
XFXianqun Fan
Xianqun Fan
Background: Large language models (LLMs) have the potential to revolutionize ophthalmic care, but their evaluation practice remains fragmented. A systematic assessment is crucial to identify gaps and guide future evaluation practices and clinical integration. Objective: This study aims to map the current landscape of LLM evaluations in ophthalmology and explore whether performance synthesis is feasible for a common task. Methods: A comprehensive search of PubMed, Web of Science, Embase, and IEEE Xplore was conducted up to November 17, 2024 (no language limits). Eligible publications quantitatively assessed an existing or modified LLM on ophthalmology-related tasks. Studies without full-text availability or those focusing solely on vision-only models were excluded. Two reviewers screened studies and extracted data across 6 dimensions (evaluated LLM, data modality, ophthalmic subspecialty, medical task, evaluation dimension, and clinical alignment), and disagreements were resolved by a third reviewer. Descriptive statistics were analyzed and visualized using Python (with NumPy, Pandas, SciPy, and Matplotlib libraries). The Fisher exact test compared open- versus closed-source models. An exploratory random-effects meta-analysis (logit transformation; DerSimonian-Laird τ2) was performed for the diagnosis-making task; heterogeneity was reported with I2 and subgrouped by model, modality, and subspecialty. Results: Of the 817 identified records, 187 studies met the inclusion criteria. Closed-source LLMs dominated: 170 for ChatGPT, 58 for Gemini, and 32 for Copilot. Open-source LLMs appeared in only 25 (13.4%) of studies overall, but they appeared in 17 (77.3%) of evaluation-after-development studies, versus 8 (4.8%) pure-evaluation studies (P80%), and findings were inconsistent (eg, pooled GPT-3.5>GPT-4). Conclusions: Evidence on LLM evaluations in ophthalmology is extensive but heterogeneous. Most studies have tested a few closed-source LLMs on text-based questions, leaving open-source systems, multimodal tasks, non-English contexts, and real-world deployment underexamined. High methodological variability precludes meaningful performance aggregation, as illustrated by the heterogeneous meta-analysis. Standardized, multimodal benchmarks and phased clinical validation pipelines are urgently needed before LLMs can be safely integrated into eye care workflows.

16 November 2023 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Closed access
HZHaiyang Zhang
Haiyang Zhang
TLTing Lu
Ting Lu
YLYuting Liu
Yuting Liu
MJMengda Jiang
Mengda Jiang
YWYishi Wang
Yishi Wang
HZHuifang Zhou
Huifang Zhou

6 March 2026 in EPMA Journal
Verified
Journal Article
Closed access
PDF file
HZHaiyang Zhang
Haiyang Zhang
LYLehan Yang
Lehan Yang
RLRunchuan Li
Runchuan Li
RBRebecca Bahn
Rebecca Bahn
HGHaixia Guan
Haixia Guan
HZHuifang Zhou
Huifang Zhou

29 April 2024 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Closed access
MJMengda Jiang
Mengda Jiang
HZHaiyang Zhang
Haiyang Zhang
YLYuting Liu
Yuting Liu
XSXuefei Song
Xuefei Song
YSYang Song
Yang Song
XTXiaofeng Tao
Xiaofeng Tao

10 February 2026 in Head & Neck
Verified
Journal Article
Closed access
LFLianfei Fang
Lianfei Fang
YLYinwei Li
Yinwei Li
YWYining Wei
Yining Wei
HZHaiyang Zhang
Haiyang Zhang
MLMing Lin
Ming Lin
HZHuifang Zhou
Huifang Zhou

28 May 2025 in Therapeutic Advances in Endocrinology and Metabolism
Verified
Journal Article
Open access
HZHaiyang Zhang
Haiyang Zhang
TLTing Lu
Ting Lu
YLYinwei Li
Yinwei Li
HGHaixia Guan
Haixia Guan
RBRebecca S. Bahn
Rebecca S. Bahn
HZHuifang Zhou
Huifang Zhou
Rituximab (RTX) is a humanized chimeric anti-CD20 monoclonal antibody that leads to immunosuppression through rapid depletion of B lymphocytes. It has been demonstrated to be useful in treating both thyroid eye disease (TED) and myasthenia gravis (MG), respectively. However, the effectiveness of RTX in concurrent TED and MG cases is unclear and not previously reported in the literature. In this study, we describe a 13-year-old girl who presented with a 10-year history of general MG and a 1-year history of Graves’ disease, bilateral proptosis, eye motility restriction, and lagophthalmos. A comprehensive evaluation confirmed the diagnosis of concurrent TED and MG. Satisfactory effectiveness was observed after RTX treatment without side effects. Based on the described observations, we suggest that RTX should be further explored as a treatment option for patients with concurrent TED and MG.